Aroa Biosurgery Appoints Two to US Commercial Team
Aroa Biosurgery Limited has appointed Michael Lynskey and Mike Falcon to its US-based commercial team. The appointments support the company's growth strategy and product adoption.
Auckland, New Zealand – Aroa Biosurgery Limited has strengthened its US-based commercial team with the appointments of Michael Lynskey and Mike Falcon. The company has been investing in expanding its commercial organization to support its growth strategy and product adoption.
Lynskey and Falcon bring significant experience in the soft tissue repair market, which is Aroa's core area of expertise. They are expected to contribute to acquiring new customers and reinforcing existing relationships within the US market.
The appointments are part of Aroa Biosurgery's broader plan to strategically expand its business operations. Recent investments in the commercial team underscore the company's commitment to increasing its market share and ensuring product availability for healthcare professionals.
The company has previously stated its objective to achieve significant growth in the coming years by leveraging its patented technology for the development of bioactive soft tissue implants.